June 2020 // Communication

Synendos Therapeutics received a prestigious European grant (SME Instrument Phase I, TWO-BIRDS project ) that helped the company to head towards clinical trials. The European commission is now reporting about the results and the perspectives to treat post-traumatic stress disorder (PTSD) and other neuropsychiatric diseases. Read the full article here.

© 2019 Synendos Therapeutics, Inc. All Rights Reserved.

  • LinkedIn - cerchio grigio
  • Twitter - cerchio grigio